Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Figurski

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Drug Monitoring|October 8, 2009
High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolitesMichal J Figurski, Magdalena Korecka, Leona Fields, et al.
Therapeutic Drug Monitoring|July 22, 2008
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporineMichal J Figurski, Artur Nawrocki, Mark D Pescovitz, et al.
Human Pathology|August 4, 2001
E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technologyM A Rubin, N R Mucci, J Figurski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2012
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patientsMichal J Figurski, Teresa Waligórska, Jon Toledo, et al.
Annals of Transplantation|April 3, 2012
Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parametersMichał J Figurski, Tomasz Pawiński, Lee R Goldberg, et al.
Clinical Chemistry|February 23, 2020
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference MethodMagdalena Korecka, Michal J Figurski, Susan M Landau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plansJu-Hee Kang, Magdalena Korecka, Michal J Figurski, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Drug Monitoring|October 8, 2009
High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolitesMichal J Figurski, Magdalena Korecka, Leona Fields, et al.
Therapeutic Drug Monitoring|July 22, 2008
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporineMichal J Figurski, Artur Nawrocki, Mark D Pescovitz, et al.
Human Pathology|August 4, 2001
E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technologyM A Rubin, N R Mucci, J Figurski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2012
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patientsMichal J Figurski, Teresa Waligórska, Jon Toledo, et al.
Annals of Transplantation|April 3, 2012
Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parametersMichał J Figurski, Tomasz Pawiński, Lee R Goldberg, et al.
Clinical Chemistry|February 23, 2020
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference MethodMagdalena Korecka, Michal J Figurski, Susan M Landau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plansJu-Hee Kang, Magdalena Korecka, Michal J Figurski, et al.
Pageof 1